HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Thomas J Sayers Selected Research
Thomas J Sayers Research Topics
Disease
33
Neoplasms (Cancer)
12/2021 - 04/2002
11
Renal Cell Carcinoma (Grawitz Tumor)
12/2021 - 03/2003
9
Neoplasm Metastasis (Metastasis)
12/2015 - 01/2003
5
Kidney Neoplasms (Kidney Cancer)
08/2006 - 04/2002
4
Melanoma (Melanoma, Malignant)
12/2021 - 12/2015
3
Breast Neoplasms (Breast Cancer)
01/2014 - 04/2010
3
Graft vs Host Disease (Graft-Versus-Host Disease)
08/2008 - 05/2004
2
Prostatic Neoplasms (Prostate Cancer)
12/2021 - 01/2017
2
Neuroblastoma
04/2009 - 05/2006
1
Experimental Melanoma
01/2021
1
Adenocarcinoma
01/2017
1
Pancreatic Neoplasms (Pancreatic Cancer)
10/2015
1
Sarcoma (Soft Tissue Sarcoma)
10/2014
1
Multiple Myeloma
07/2010
1
Esophageal Squamous Cell Carcinoma
06/2010
1
Human Influenza (Influenza)
08/2009
1
Hematologic Neoplasms (Hematological Malignancy)
08/2008
1
Carcinogenesis
01/2006
1
Colonic Neoplasms (Colon Cancer)
11/2005
1
Lymphoma (Lymphomas)
06/2004
1
Leukemia
05/2004
1
Myeloid Leukemia (Leukemia, Myelocytic)
07/2003
1
Aplastic Anemia (Anemia, Hypoplastic)
05/2003
Drug/Important Bio-Agent (IBA)
12
Ligands
IBA
01/2021 - 01/2003
11
Bortezomib (Velcade)
FDA Link
12/2015 - 07/2003
10
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
02/2017 - 04/2002
6
Proteins (Proteins, Gene)
FDA Link
01/2021 - 01/2003
6
Proteasome Inhibitors
IBA
12/2015 - 05/2004
5
Fas Ligand Protein (Fas Ligand)
IBA
06/2014 - 04/2002
5
Perforin
IBA
08/2009 - 04/2002
5
Proteasome Endopeptidase Complex (Proteasome)
IBA
01/2008 - 05/2004
4
Cytokines
IBA
05/2012 - 11/2004
4
TNF-Related Apoptosis-Inducing Ligand
IBA
07/2010 - 05/2005
3
Withanolides
IBA
02/2017 - 01/2017
3
Antibodies
IBA
08/2011 - 01/2003
3
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
07/2010 - 02/2004
3
Interleukin-2 (IL2)
IBA
04/2009 - 03/2003
2
physachenolide C
IBA
12/2021 - 01/2021
2
Poly I-C
IBA
12/2021 - 01/2021
2
Antineoplastic Agents (Antineoplastics)
IBA
02/2017 - 01/2006
2
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
12/2015 - 08/2009
2
Antigens
IBA
12/2015 - 08/2009
2
Death Domain Receptors
IBA
10/2015 - 01/2003
2
Peptides (Polypeptides)
IBA
05/2012 - 08/2009
2
Interleukin-12 (IL 12)
IBA
05/2006 - 11/2004
1
Polynucleotides
IBA
01/2021
1
rocaglamide
IBA
11/2018
1
Androgens
IBA
01/2017
1
Interleukin-2 Receptors (IL 2 Receptor)
IBA
12/2015
1
Aldehyde Dehydrogenase
IBA
10/2015
1
pazopanib
FDA Link
10/2014
1
regorafenib
IBA
10/2014
1
Sorafenib (BAY 43-9006)
FDA Link
10/2014
1
Tyrosine Kinase Inhibitors
IBA
10/2014
1
Secretory Leukocyte Peptidase Inhibitor
IBA
01/2014
1
Drug Combinations
IBA
10/2012
1
Cucurbitacins
IBA
01/2012
1
Toll-Like Receptor Agonists
IBA
07/2010
1
Hazardous Substances (Hazardous Materials)
IBA
06/2010
1
Isotopes
IBA
06/2010
1
Caspase 8 (Caspase-8)
IBA
05/2010
1
Viral Hemagglutinins
IBA
08/2009
1
Interleukin-27 (Interleukin 27)
IBA
04/2009
1
Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)
IBA
08/2006
1
NK Cell Lectin-Like Receptor Subfamily K
IBA
08/2006
1
Cycloheximide (Cicloheximide)
IBA
05/2005
1
Lectins
IBA
11/2004
1
Interleukins
IBA
11/2004
1
Interleukin-18 (Interleukin 18)
IBA
11/2004
1
Granzymes (Granzyme)
IBA
06/2004
1
Monoclonal Antibodies
IBA
02/2004
1
Fc Receptors (Fc Receptor)
IBA
02/2004
1
Enzymes
IBA
01/2003
Therapy/Procedure
12
Therapeutics
02/2017 - 01/2003
8
Immunotherapy
12/2021 - 11/2004
3
Bone Marrow Transplantation (Transplantation, Bone Marrow)
08/2008 - 05/2004
2
Drug Therapy (Chemotherapy)
12/2021 - 10/2012
1
Neoadjuvant Therapy
10/2014
1
Aftercare (After-Treatment)
06/2014
1
Radiotherapy
10/2012
1
Homologous Transplantation
08/2008
1
Transplantation
05/2003
1
Biological Therapy
04/2002